# G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes

> **NCT03738865** · PHASE3 · COMPLETED · sponsor: **Xeris Pharmaceuticals** · enrollment: 132 (actual)

## Conditions studied

- Insulin Hypoglycemia
- Type 1 Diabetes Mellitus
- Severe Hypoglycemia

## Interventions

- **DRUG:** G-Pen
- **DRUG:** Novo Glucagon

## Key facts

- **NCT ID:** NCT03738865
- **Lead sponsor:** Xeris Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-27
- **Primary completion:** 2019-03-29
- **Final completion:** 2019-04-02
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2020-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03738865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03738865, "G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03738865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*